首页> 外文期刊>Progress in Artificial Intelligence >LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2
【24h】

LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2

机译:LNCRNA LOXL1-AS1通过海绵MIR-423-5P调节肺腺癌的肿瘤引发和发育,并瞄准MYBL2

获取原文
获取原文并翻译 | 示例
           

摘要

Lung adenocarcinoma (LUAD) is the most common form of malignant tumor and closely correlated with high risk of death worldwide. Accumulating researches have manifested that long noncoding RNAs (lncRNAs) are deeply involved in the progression of multiple cancers. LncRNA LOXL1 antisense RNA 1 (LOXL1-AS1) was identified as an oncogene in several cancers, nonetheless, its biological effect and regulatory mechanism have not been explained in LUAD. Our present study suggested that LOXL1-AS1 expression was considerably increased in LUAD tissues and cells. Moreover, LOXL1-AS1 deficiency notably hampered cell proliferation and migration as well as dramatically facilitated cell apoptosis. Through molecular mechanism assays, LOXL1-AS1 was identified as a cytoplasmic RNA and acted as a sponge of miR-423-5p. Furthermore, MYBL2 was targeted and negatively modified by miR-423-5p. Rescue experiments revealed that MYBL2 knockdown could counteract miR-423-5p repression-mediated enhancement on the progression of LOXL1-AS1 downregulated LUAD cells. More importantly, MYBL2 was discovered to interact with LOXL1-AS1 promoter, indicating a positive feedback loop of LOXL1-AS1/miR-423-5p/MYBL2 in LUAD. These findings manifested the carcinogenic role of LOXL1-AS1 and LOXL1-AS1/miR-423-5p/MYBL2 feedback loop in LUAD, which could be helpful to explore effective therapeutic strategy for LUAD patients.
机译:肺腺癌(Luad)是最常见的恶性肿瘤形式,与全世界的高死亡风险密切相关。积累的研究表明,长度非编码RNA(LNCRNA)深受多种癌症的进展。 LNCRNA LOXL1反义RNA 1(LOXL1-AS1)在几种癌症中被鉴定为癌基因,仍未在拉德解释其生物学效应和调节机制。我们现在的研究表明,管道组织和细胞中LOX11-AS1表达显着增加。此外,LOXL1-AS1缺乏率显着阻碍了细胞增殖和迁移以及显着促进的细胞凋亡。通过分子机制测定,将LOX11-AS1鉴定为细胞质RNA,并用作miR-423-5p的海绵。此外,MyBl2被MiR-423-5P针对性和负面修饰。救援实验表明,Mybl2敲低可以抵消MiR-423-5P抑制介导的介导的增强LOXL1-AS1下调的路障细胞的进展。更重要的是,发现MyBl2与LOXL1-AS1启动子相互作用,表明路障中LOXL1-AS1 / MIR-423-5P / MYBL2的正反馈回路。这些发现表现出LOXL1-AS1和LOXL1-AS1 / MIR-423-5P / MYBL2 / MYBL2反馈环路的致癌作用,这可能有助于探索水拉患者的有效治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号